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A 36‐year old female with acute myelogenous leukemia presented with a sudden decrease in vision one 
month following bone marrow transplantation (BMT). She had been taking multiple immunosuppressants to 
treat her recently‐developed graft‐versus‐host‐disease (GVHD). Visual acuity was 20/60 in her right eye and 
20/25 in her left. Ophthalmic examination revealed mild inflammatory reaction in both the anterior chamber 
and the vitreous of both eyes, as well as densely opaque yellow‐white infiltrates with well‐demarcated 
borders in the posterior retina of both eyes. She was originally diagnosed as CMV retinitis, but treatment 
with ganciclovir failed to improve her ocular condition. Subsequent work‐up, including serology and brain 
MRI, led to a diagnosis of combined ocular and cerebral toxoplasmosis. After 6 weeks of antiparasitic 
therapy, her retinal lesions became inactive and her cerebral lesions improved.
Immunosuppressed patients with necrotizing retinochoroiditis should be suspected of having toxoplasmosis. 
Accurate differentiation between this condition and CMV, and early intervention with the appropriate 
treatment may be critical to preserve the best vision.
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Case Report
A 36‐year‐old woman who had undergone allogeneic bone 
marrow transplantation (BMT) for acute myelogenous 
leukemia (M4) 2 months previously was referred with a 
complaint of decreased vision for 2 days.
Since BMT, she had been under multiple regimens 
including intravenous ciprofloxacin, fluconazole and acyclovir 
as a prophylaxis for bacterial, fungal and herpes viral 
infections. For the prophylaxis for Pneumocystis pneumonia, 
monthly inhalation of pentamidine (a dose of 300mg in a 
nebulizer) was used and trimethoprim/sulfamethoxazole was 
not given. She also had been taking methylprednisolone (1.9 
mg/kg, daily), cyclosporine (1.4 mg/kg, daily) and myco- 
phenolate mofetil (7.1 mg/kg, daily) for the treatment of 
BMT‐induced graft‐versus‐host‐disease (GVHD).
Ophthalmic examination revealed visual acuity of 20/60 in 
the right eye and 20/25 in the left. There were mild cellular 
reactions in the anterior chambers and vitreous humors of 
both eyes. Densely opaque, yellow‐white curvilinear infiltrates 
of 2 disc area size were observed with a small satellite lesion 
at the posterior retina of her right fundus. A similar infiltrate 
was also identified temporal to the macula in her left eye 
(Fig. 1). No retinal hemorrhage was found. Blood test 
showed positive CMV antigenemia (12/200,000 WBC). 
Necrotizing retinitis in the posterior pole with CMV 
antigenemia in this immunocompromised patient prompted us 
to make diagnosis of CMV retinitis. However, despite 2 
weeks treatment with intravenous ganciclovir (2.5 mg/kg 
daily, dose adjusted to her glomerular filtration rate), her 
retinal lesion worsened and new satellites appeared (Fig. 2). 
In addition her vision had decreased to 20/400 in the right 
eye, and 20/60 in the left.
A subsequent blood test revealed the negative conversion 
of CMV antigenemia, but showed positive for serum 
toxoplasmosis antibody (both IgM and IgG by ELISA). At 
this time, the patient’s mental status changed for the worse 
and a brain imaging was performed. The finding of 
multifocal, ill‐defined nodular enhancing lesions in cerebral, 
cerebellar hemispheres and basal ganglia was consistent with 
toxoplasmic involvement of CNS (Fig. 3). The cerebrospinal 
fluid analysis was normal in cell counts, protein and glucose 
and the CSF culture for fungus and bacteria were all 
negative. 
With a presumed diagnosis of concomitant toxoplasmic Korean J Ophthalmol Vol.22, No.3, 2008
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Fig. 1. Fundus photographs and optical coherence tomography (OCT) at presentation in the patient’s right (a, b) and left (c, d) eyes.
Her visual acuity was 20/60 in the right eye and 20/25 in the left eye. 
Fig. 2. Fundus photographs of both eyes 2 weeks after the initiation of intravenous ganciclovir (a, b). Her visual acuity had decreased
to 20/400 in the right eye and 20/60 in the left eye. 
retinochoroiditis and encephalitis, trimethoprim/sulfamethoxazole 
5 mg/kg PO BID and clindamycin 600 mg PO QID were 
started. One week later, the cellular reaction in her anterior 
chambers and vitreous cavities had disappeared, and the size 
and thickness of her retinal infiltrates were decreased 
markedly. Brain MRI showed improvement as well. The 
inflammatory retinal lesion became inactive following six 
weeks of therapy; however her right vision failed to improve 
because of macular involvement (Fig. 4). Visual acuity at the 
last follow‐up was 20/400 in the right eye and 20/80 in the 
left eye. Brain MRI taken after 6 weeks of therapy showed 
little evidence of any lesions. At four months after 
discontinuation of treatment, there was no evidence of ocular 
or intracranial recurrence.HW Chung, et al. TOXOPLASMA RETINOCHOROIDITIS SIMULATING CMV
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Fig. 3. Magnetic resonance imaging of the brain showing multifocal, ill-defined nodular enhancing lesions in both cerebral hemispheres 
and basal ganglia.
Fig. 4. Fundus photographs and OCT of right eye (a, b) and left (c, d) after 6 weeks of antiparasitic therapy. Her visual acuity 
remained poor due to the formation of epiretinal membrane and atrophy of her neurosensory retinas.
Discussion
In this study, we have described one interesting case of 
toxoplasmic retinochoroiditis simulating CMV retinitis with 
concurrent cerebral toxoplasmosis after allogeneic BMT. In 
our case, positive serum toxoplasma serology, no use of 
trimethoprim/sulfamethoxazole as a prophylaxis for 
Pneumocystis pneumonia after BMT, exacerbation of the 
condition after intravenous ganciclovir treatment, apparent 
good response to antiparasitic therapy and concurrent 
encephalitis with multiple nodular brain lesions suggested 
toxoplasmosis.
Differential diagnosis of necrotizing retinochoroiditis in 
immunocompromised hosts has been challenging.
1‐4 
Compared with CMV retinitis, toxoplasmic retinochoroiditis 
has clinical features of mild to moderate inflammatory 
reactions in the anterior chambers and vitreous, an absence 
of retinal hemorrhages, and opacified retinas that appear 
thicker and more densely white‐yellow. In addition, the 
borders of the lesions are better defined and smoother in 
contour. While CMV has become the most frequent cause of 
necrotizing retinochoroiditis since the advent of AIDS, other Korean J Ophthalmol Vol.22, No.3, 2008
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causes such as toxoplasmosis or herpes should be considered 
as a possible pathogen. Therefore, one should perform serum 
toxoplasma serology in such patients, especially when 
exacerbation of the condition was noted following 
intravenous ganciclovir treatment like in our case. 
Our case holds additional several interesting characteristics: 
1) development of retinal hemorrhage during the aggravation 
phase, 2) concurrent encephalitis which has rarely been 
reported in non‐AIDS ocular toxoplasmosis cases, and 3) 
bilateral simultaneous involvement unlike most cases which 
are either unilateral or sequentially bilateral.
1,3,4
Toxoplasmosis in the immunocompromised including 
BMT patients was known to be usually through reactivation 
of latent infection.
5 Because IgM for toxoplasmosis could last 
for several years and we had not performed the serology test 
for toxoplasmosis in both the patient and the donor before 
BMT, it is difficult to assume the accurate routes of infection. 
However, primary infection via donor marrow or transfusion 
also could be a possible mode of infection considering her 
positive toxoplasmosis IgM.
In conclusion, toxoplasmic retinochoroiditis in immunosuppresed 
patients is very different from that in immunocompetent 
patients, and can be easily confused with CMV retinitis. 
Toxoplasmosis should be considered as a pathogen for the 
necrotizing retinochoroiditis in immunocompromised patients 
with anti‐CMV therapy failures. High index of suspicion is 
essential to make an accurate differential diagnosis.
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